Fig. 2From: Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter studyLSM baseline and at the last visit of the patients with advanced fibrosis (≥ 9 kPa) (p = 0.001) compared with the patients with no advanced fibrosis (p = 0.01)Back to article page